Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials.

about

Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials.

Item

http://www.wikidata.org/entity/Q39034554

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Time-to-event endpoints in ope ...... er randomized clinical trials.

@en

Time-to-event endpoints in ope ...... er randomized clinical trials.

@nl

type

Item

label

Time-to-event endpoints in ope ...... er randomized clinical trials.

@en

Time-to-event endpoints in ope ...... er randomized clinical trials.

@nl

prefLabel

Time-to-event endpoints in ope ...... er randomized clinical trials.

@en

Time-to-event endpoints in ope ...... er randomized clinical trials.

@nl

P1476

Time-to-event endpoints in ope ...... er randomized clinical trials.

@en

P2093

Franck Bonnetain

http://www.w3.org/2001/XMLSchema#string

Frédéric Fiteni

http://www.w3.org/2001/XMLSchema#string

Marie-Justine Paillard

http://www.w3.org/2001/XMLSchema#string

Virginie Westeel

http://www.w3.org/2001/XMLSchema#string

P2860

American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

P304

167-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2016.1271718

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27937067

http://www.w3.org/2001/XMLSchema#string